Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
NurOwn (MSC-NTF cells)
BIOLOGICAL
2 trials
Sponsors
Brainstorm-Cell Therapeutics
Conditions
Amyotrophic Lateral Sclerosis
Multiple Sclerosis, Chronic Progressive
Phase 2
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS
Completed
NCT03799718
Brainstorm-Cell Therapeutics
Multiple Sclerosis, Chronic Progressive
Start: 2019-03-13
End: 2021-03-30
Updated: 2023-12-04
Unknown Phase
Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS
NCT04681118
Brainstorm-Cell Therapeutics
Amyotrophic Lateral Sclerosis
Updated: 2024-04-23